The Atlanta Journal-Constitution

True viral death rate still eludes experts

Former CDC chief calls 3.4% mortality figure ‘an overestima­te.’

- By Marthe Fourcade and John Lauerman

Even the world’s top infectious-disease specialist­s still aren’t sure how lethal a threat the coronaviru­s presents.

World Health Organizati­on Director-General Tedros Adhanom Ghebreyesu­s said this week that the new virus has killed about 3.4% of those diagnosed, a chilling mortality upgrade that far eclipses seasonal flu’s death toll.

Tedros’ ballpark figure reflects a simple calculatio­n, based on the number of deaths and confirmed cases. Pinpointin­g a reliable mortality rate may be tougher, especially since many patients may be flying below the radar, which could dramatical­ly lower the real toll of the disease. A lot is riding on health officials’ best guesses — including their strategy for responding to the spread.

The 3.4% mortality figure “is certainly an overestima­te,” Tom Frieden, a former director of the U.S. Centers for Disease Control and Prevention and New York City health commission­er, said by email.

The WHO said the mortality rate is a “snapshot” that will inevitably change as the outbreak evolves.

Frieden said he expects that the global fatality rate for the disease, called COVID-19, will end up below 1%. In the U.K., the death rate may also be lower than that threshold, the government’s chief medical adviser, Chris Whitty, told a parliament­ary committee Thursday.

Even that would be higher than the death rate from the flu, which was about 0.1% in recent outbreaks, according to CDC data. Though it would be well below the roughly 10% toll for the earlier SARS outbreak, the new coronaviru­s could still cause a huge number of deaths if it eventually spreads to millions of people worldwide, as some experts say it could.

About 80% of people who get coronaviru­s have only mild symptoms, according to the WHO. Some experience none at all, and different testing regimes across the world cloud the picture further. If many cases go unrecogniz­ed, it allows the virus to stealthily gain a foothold in communitie­s as well as evade tallying in the WHO ledger that experts use for analysis.

“A lot of people are asymptomat­ic,” said Rosanna Peeling, director of the Internatio­nal Diagnostic­s Center at the London School of Hygiene and Tropical Medicine. “We’re only seeing the cases that are confirmed and the cases of people presenting to the hospital because they can’t breathe.”

Some countries have opted to check aggressive­ly. South Korea has conducted 140,000 tests in a short time that have uncovered about 5,700 infections. Singapore is swabbing all visitors who enter the island nation with symptoms of respirator­y illness.

Japan, meantime, had tested fewer than 3,000 people as of March 3, finding 317 infections. In the U.S., health officials are trying to speed diagnosis after struggling with a number of early glitches.

Most countries follow WHO guidelines, which limit the scope of tests by establishi­ng criteria for suspected cases. They call for checking patients who’ve had symptoms and traveled to countries where the new virus has taken hold, like China, Iran or Italy, or who came into contact with a confirmed case. They’re also testing those admitted to a hospital with severe pneumonia.

When Italy strayed from the agency’s testing recommenda­tions, its caseload swelled, rising to more than 3,000 as of Thursday — the most outside Asia. Health authoritie­s there counted hundreds of people who had the virus with hardly any symptoms.

Those that test the most show lower mortality rates from the coronaviru­s. So while the global rate may be above 3% of some 96,000 cases, it’s below 1% in South Korea. Whether that’s due to a more effective policy response, better medical care or more favorable mathematic­s remains unclear.

 ?? OLIVER BUNIC / BLOOMBERG ?? A lab tech in biohazard coveralls does coronaviru­s tests Wednesday in an isolation chamber at a laboratory in the Torlak Institute of Virology in Belgrade, Serbia.
OLIVER BUNIC / BLOOMBERG A lab tech in biohazard coveralls does coronaviru­s tests Wednesday in an isolation chamber at a laboratory in the Torlak Institute of Virology in Belgrade, Serbia.

Newspapers in English

Newspapers from United States